DJ Catalyst Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ advanced 1.17% to $25.94 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.64% to 24,657.57 and the Dow Jones Industrial Average rising 0.69% to 49,490.03.
The stock's rise snapped a two-day losing streak.
Catalyst Pharmaceuticals Inc. closed 2.41% below its 52-week high of $26.58, which the company achieved on June 9th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.03% to $226.10, Pfizer Inc. $(PFE)$ fell 1.87% to $26.80, and Abbott Laboratories $(ABT)$ fell 1.10% to $91.70.
Trading volume (702,664) remained 559,874 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 22, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 22, 2026 17:23 ET (21:23 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.